The Future of Diversity in Clinical Trials: Real-World Evidence
This episode of tHEORetically Speaking features real-world evidence experts Alexandrina Balanean, Parisa Asgarisabet, and Danielle Gentile from Cardinal Health discussing the problems caused by lack of diverse representation in clinical trials.
Real-World Data Can Bring Value to Life Sciences Companies Operating in a Value-Based World
The healthcare industry -- from providers and health systems to payers -- is increasingly adopting [...]
Whitepaper on Artificial Intelligence and Machine Learning in Clinical Trials
Medical imaging data obtained during clinical trials contains valuable data. As pharmaceutical companies consider using time-saving and efficient artificial intelligence [...]
Designing Clinical Trials During COVID-19 ERA
The ongoing pandemic has led to chaos in many industries, including in clinical trial design. The use of RWE (real [...]
Advertisement
